Actively Recruiting
Study of Rosuvastatin to Prevent Heart and Organ Problems After Surgery for Acute Aortic Syndrome
Led by Nanjing Medical University · Updated on 2024-12-13
300
Participants Needed
5
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Acute Aortic Syndrome AAS and Aortic Aneurysm involve serious aortic wall conditions such as aortic dissection, intramural hematoma, ulceration, and trauma, mostly affecting people aged 65 to 75 years. Elevated levels of the inflammatory marker high-sensitivity C-reactive protein are linked to cardiovascular events. Researchers are studying whether statins can help people with AAS who do not have high cholesterol but have other cardiovascular risk factors. The trial compares the use of Rosuvastatin 10mg taken daily by mouth or nasal feeding with no intervention after surgery for acute aortic syndrome. Participants receive either the statin treatment or no treatment following aortic arch replacement, endoluminal isolation, or hybrid therapy. The study uses a randomized, triple-blind design to assess the effects of statin treatment on cardiovascular health after surgery. Participants will be monitored for aortic adverse events and mortality three months after surgery. The study involves consent, regular follow-up, and evaluation of cardiovascular and organ function outcomes. Researchers will measure the occurrence of complications and survival rates to understand the protective effects of statins in this group. The study includes adults aged 18 to 85 years without significant hyperlipidemia but with cardiovascular risk factors.
CONDITIONS
Brief Title
Protective Effect of Statin Against Negative Cardiovascular Remodeling and Organ Dysfunction After Acute Aortic Syndrome Surgery (PANDA III)
Research Team
H
Hong Liu, MD
Y
Yong-feng SHAO, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here